Premarket Mover: Landos Biopharma Inc (LABP) Up 964.52%

Landos Biopharma Inc (LABP) has gained Friday morning, with the stock adding 964.52% in pre-market trading to 3.3. LABP's short-term technical score of 75 indicates that the stock has traded more bullishly over the last month than 75% of stocks on the market. In the Biotechnology industry, which ranks 81 out of 146 industries, the stock ranks higher than 78% of stocks. Landos Biopharma Inc has risen 6.90% over the past month, closing at $0.28 on April 28. During this period of time, the stock fell as low as $0.28 and as high as $0.35. LABP has an average analyst recommendation of Sell. The company has an average price target of $0.55.

LABP has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on LABP!

See Full LABP Report

Landos Biopharma Inc has a Long-Term Technical rank of 43. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 57% of the market scoring higher. In the Biotechnology industry which is number 74 by this metric, LABP ranks better than 74% of stocks.

Important Dates for Investors in LABP:

-Landos Biopharma Inc is set to release earnings on 8/10/2023. Over the last 12 months, the company has reported EPS of $-0.09. -We do not have a set dividend date for Landos Biopharma Inc at this time. Click Here To Get The Full Report on Landos Biopharma Inc (LABP)